Navigation Links
Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
Date:11/29/2007

Management and Third-Party Investigators to Conduct Conference Call on December 10, 2007 to Discuss SNS-595 Clinical Trial Results and SNS-032

Non-clinical Data

SOUTH SAN FRANCISCO, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company developing novel anticancer therapeutics, today announced that it will present data on the company's two lead product candidates, SNS-595 and SNS-032, at the upcoming 49th Annual Meeting of the American Society of Hematology (ASH). This year's conference will be held December 8-11, 2007 at the Georgia World Congress Center in Atlanta, Georgia. On December 10, 2007, Sunesis management will host a conference call for investors to discuss the data being presented.

Jeffrey Lancet, M.D., of the H. Lee Moffitt Cancer Center & Research Institute will present results from Sunesis' Phase 1 clinical trial of SNS-595, a replication-dependent DNA damaging agent, as part of the oral session "Acute Myeloid Leukemias: Therapy, excluding Transplantation-Novel Therapies." The presentation, titled "SNS-595 Demonstrates Clinical Responses in a Phase 1 Study in Acute Leukemia," (Abstract no. 442), will be conducted in Room A411-A412 at 2:15 p.m. Eastern Time on Monday, December 10, 2007.

In addition, the company will present non-clinical data on SNS-032, a cyclin-dependent kinase (CDK) inhibitor, during poster session "CLL: Salvage Therapies and New Agents." The poster, "Mechanism of Action of SNS-032, a Novel Cyclin Dependent Kinase Inhibitor, in Chronic Lymphocytic Leukemia: Comparison with Flavopiridol" (Abstract no. 3112) will be presented in Hall B4 of the Georgia World Con
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets has announced the ... Strategic Business Report" report to their offering. ... Hormone Drugs in US$ Million by the following Brands: Humatrope, ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of ...
(Date:8/19/2014)... , Aug. 19, 2014  AVIA – a provider-led ... on the biggest problems in healthcare ­– announces Sutter ... California , as the most recent addition to ... will participate in AVIA,s inaugural cohort focused helping patients ... and transparency among a patient,s providers so they work ...
(Date:8/19/2014)... RESTON, Va. , Aug. 19, 2014 ... today announced that it has closed an equity financing ... Investors and Middleland Capital. The new funding will be ... company. With this financing round, Avizia welcomes Edward ... its board of directors. He joins Leonard Kurtzman ...
Breaking Medicine Technology:Global Human Growth Hormone Drugs - Strategic Business Report 2014 2AVIA and Sutter Health Join Forces to Address Healthcare's Most Pressing Challenges 2Avizia Closes Funding Round 2
... 12, 2011 Qualcomm Incorporated (NASDAQ: QCOM ... Province, Korea Centers for Disease Control and Prevention (KCDC), ... a Memorandum of Understanding for a project that will ... Self Quality Care , which will utilize 3G-enabled ...
... 11, 2011 Roper Industries, Inc. (NYSE: ... its conference call to discuss first quarter 2011 results ... thirty minutes earlier than originally scheduled.  The call can ... (US/Canada) or +1 719-457-2639, using confirmation code 5338709.  Webcast ...
Cached Medicine Technology:Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 2Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 3Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 4
(Date:8/19/2014)... Top10BestSEOHosting.com has recently announced that FatCow ( ... for the webmasters who want to buy high ... the senior spokesman for Top10BestSEOHosting.com, these two companies ... on the market and specializes in offering efficient ... deals when service plans are purchased online. , ...
(Date:8/19/2014)... 19, 2014 The National Cannabis ... Annual Southwest CannaBusiness Symposium on Saturday, August 23, ... Casino in Las Vegas. , Featuring keynotes by U.S. ... Segerblom (D-Las Vegas), the event will also include in-depth ... work NCIA is doing federally to advance a legitimate ...
(Date:8/19/2014)... 19, 2014 In honor of National Dog Day ... your old furry friend by offering tips on caring for aging ... owners more. Because of this, dog owners need to realize the ... dogs age, their needs change. They will not want to spend ... they used to. Because of this, pet owners should consider altering ...
(Date:8/19/2014)... developed by University of Kentucky Markey Cancer Center researchers will ... which brain tumor cases require testing for a genetic mutation. ... the brain or spine are the most common and ... 80 percent of malignant brain cancer cases. In some of ... known as an IDH1 mutation and patients who have ...
(Date:8/19/2014)... August 19, 2014 Title Boxing Club ... launched a Facebook Sweepstakes giving away prizes – including ... enter visit http://www.facebook.com/titleboxingcoolsprings and click on the ... and for each one that enters, you will receive ... is the final week to take advantage of the ...
Breaking Medicine News(10 mins):Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2Health News:SATURDAY IN LAS VEGAS: U.S. Rep. Dina Titus, State Sen. Tick Segerblom Keynote National Cannabis Industry Association Southwest CannaBusiness Symposium 2Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Title Boxing Club Cool Springs is Officially Open 2
... remediation or cognitive enhancement, education, psychotherapy, and behavioral ... combating negative symptoms of schizophrenia. ,An ... ‘negative’ symptoms have more effect on the quality ... ‘psychotic or positive’ symptoms like hallucinations and delusions. ...
... hospital in Kolkata as here the disease has been contained ... Disease Control Programme. // ,Speaking at an ... in Kolkata only person died of Malaria whereas in Bombay ... of UP, Bihar, Jharkhand Orissa, Assam and Pondichery participated in ...
... products, disinfectants, and sanitizers to food benefits people ... foods. ,According to the Institute of ... other antimicrobial treatments in the manufacturing processes of ... nothing related to hinder health. ,In ...
... an MoU with a leading the Netherlands-based private equity house ... catering to the Indian market within the next nine months. ... fund, for which YES Bank would be the advisor., ... which is currently Europe-centric., ,"The fund will get into ...
... Biotechnology (CIGB) has registered the first recombinant monoclonal antibody ... B vaccine. // ,CIGB Deputy Director General ... breakthrough, and it was obtained after having completed all ... , ,At a press conference in Havana, Borroto ...
... at first eventually Neemuch, a town in Madhya Pradesh, soon grew ... ,Over 3,000 people in India have had their vision restored to ... Garg from Neemuch had pledged his eyes before he died because ... that the town has the highest per capita eye donation rate ...
Cached Medicine News:Health News:Antibacterial Products Ensure Food Safety and Health 2Health News:Antibacterial Products Ensure Food Safety and Health 3Health News:Antibacterial Products Ensure Food Safety and Health 4Health News:Antibacterial Products Ensure Food Safety and Health 5
... camera photomicrographic system can be mounted on ... Leica, Nikon, and Zeiss, making building an ... the Internet easy and fast. Featuring a ... lens. The system records photomicrographic images (2,272 ...
... The AxioCam HR from Carl Zeiss ... microscopy expert. Not only does it generate ... it is also optimally adjusted to work ... the software. What's more it also allows ...
... camera systems for qualified microscopic documentation. The ... images of highest color fidelity, resolution and ... can rely on access to perfect images ... advantages and innovative readout modes make this ...
Coolpix 4500 microscope package includes Coolpix 4500 digital camera, MDC-A relay lens and EH52 AC adapter....
Medicine Products: